infectious disease research News
-
Single Cell Sequencing: Transform Your Immunology and Cancer Research from Bulk to Single Cell Analysis
Single cell sequencing has transformed our ability to discern the cellular and molecular makeup of human immune systems and tissues in a unique manner with a level of precision that other “omic” technologies are unable to provide. Coupled with rigorous analysis, this technology is able to identify rare cell populations/subtypes and provide novel insights about pathways and thus ...
-
NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GAITHERSBURG, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced the formation of its Autoimmune and Infectious Disease Scientific Advisory Board (AI & ID SAB). The AI ...
-
BOHS – COVID-19: Occupation Risk Rating and Control Options According to Exposure Rank
At a time where there is increasing focus on controlling the spread of infection in public, the British Occupational Hygiene Society is issuing a risk analysis tool for professionals to focus on the most appropriate measures to help employers reduce the risk of catching COVID-19 at work. The British Occupational Hygiene Society, the Chartered Society for Worker Health Protection and a ...
-
N8 Medical Appoints Infectious Diseases Expert, David S. Perlin, Ph.D., to Scientific Advisory Board
N8 Medical, a clinical-stage biopharmaceutical company focused on developing novel combination medical devices and antifungal and anti-bacterial therapeutics for the prevention and treatment of serious and life-threatening infections, announced today that it appointed David S. Perlin, Ph.D. to its Scientific Advisory Board (SAB). Dr. Perlin is an internationally recognized expert and research ...
-
BOHS - COVID-19: Occupation Risk Rating and Control Options According to Exposure Rank
At a time where there is increasing focus on controlling the spread of infection in public, the British Occupational Hygiene Society is issuing a risk analysis tool for professionals to focus on the most appropriate measures to help employers reduce the risk of catching COVID-19 at work. The British Occupational Hygiene Society, the Chartered Society for Worker Health Protection and a ...
-
NanoPin Technologies Founder`s Study Demonstrates Greater Accuracy in Detecting TB in Infants
NanoPin Technologies Inc, a biotechnology company focused on developing advanced diagnostics to improve the lives of millions of individuals affected by infectious diseases worldwide, announced the release of a scientific study conducted by founder Tony Hu, Ph.D. Dr. Hu is a professor and Weatherhead Presidential Chair in Biotechnology Innovation at the Tulane University School of Medicine. ...
-
Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections
Imbed Biosciences, Inc. announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP) to accelerate clinical development of an antibiofilm version of its next-generation Microlyte® Matrix wound dressing that can kill bacteria hidden in biofilms. The contract ...
-
India`s poultry industry adds to drug resistance
Chickens farmed for meat and eggs in India’s Punjab state harbour high levels of antibiotic-resistant bacteria, says a new Indo-US study. “Misuse of antibiotics in animal farms endangers all of us because it multiplies drug resistance in the environment,” says Ramanan Laxminarayan, director of the Washington-based Center for Disease Dynamics, Economics and Policy, and who ...
By SciDev.Net
-
Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious ...
-
ECCMID 2020 Alert: Selux Diagnostics Hosting Integrated Symposium at 30th European Congress of Clinical Microbiology & Infectious Diseases
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antimicrobial resistance, today announced it will host an integrated symposium on aspects that impact antimicrobial resistance, rapid diagnostics and clinical care at this spring's 2020 European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Paris, France. ...
-
Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program
To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific today announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the pandemic globally. Under the program, the company will provide 50 units of the Ion Torrent Genexus System at a ...
-
Stilla and Promega Announce Co-Marketing Agreement to Offer Complete Digital PCR Workflow Solution
Stilla Technologies, the multiplex digital PCR company, and Promega Corporation today announced a co-marketing agreement that combines sample preparation with the latest Maxwell® systems and digital PCR on the six-color naica® system. With this partnership, the companies will offer an optimized workflow for a wide range of applications including liquid biopsy, sentinel pathogen testing, ...
-
Showcase
Empatica partnering with U.S. Army MRDC to deploy COVID-19 early detection wearable
BOSTON, Nov. 6, 2020 /PRNewswire/ -- Empatica has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enable the early and pre-symptomatic detection of COVID-19. The project's focus is on protecting the health of the general population by preventing outbreaks via early detection and alerting. Empatica's Aura algorithm gives a ...
-
Smiths Detection’s BioFlash shown to detect airborne COVID-19
Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The tests were performed using live SARS-CoV-2 virus in a Biosafety Level 3 containment area ...
-
The Francis Crick Institute CHP Plant
The Francis Crick institute is being built in central London next to St Pancras International station. By bringing together scientists from all disciplines, it will not only help to improve people’s lives but will also keep the UK at the forefront of innovation in medical and bioscience research, attract high-value investment, and strengthen the economy. Francis Crick was one of ...
-
BlueWillow Biologics Names Leading Viral Infectious Disease Experts to Scientific Advisory Board
BlueWillow Biologics, Inc., a privately held clinical-stage biopharmaceutical company developing intranasal vaccines, today announced the formation of the Company’s Scientific Advisory Board (SAB) with three leading viral infectious disease experts. The SAB will provide strategic and scientific counsel to BlueWillow’s clinical programs. The members of the BlueWillow Biologics SAB ...
-
Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS-based metabolomics services for biomedical research institutions as well as biotechnological and pharmaceutical companies. The company launches the drug-resistant metabolomics research service for oncology research and infectious disease studies regarding drug resistance. Drug therapy is one of the ...
-
Virometix Broadens Senior Leadership Team with Three Key Appointments
Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, today announced the expansion of its leadership team with the appointment of a Chief Scientific Officer and two additional Board members. Virometix filled a vacancy in its management team with the ...
By Virometix AG
-
CD Genomics Accelerates RNA Research with the Launch of Nanopore Direct Sequencing
CD Genomics, a global leader in transcriptomics solutions, unveils its mature Nanopore Direct RNA Sequencing service that can propel transcriptomics research to new heights. With this service, CD Genomics empowers researchers to unlock the full potential of their studies with unrivalled precision and efficiency. Harnessing the power of Oxford Nanopore sequencing technology, this revolutionary ...
By CD Genomics
-
Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, and the Translational Genomics Research Institute (TGen), part of City of Hope, today announced a partnership to explore the utility of the Nautilus platform by studying specific protein targets in diffuse intrinsic pontine glioma (DIPG), a rare and often fatal ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you